HF
CDIO icon

HRT Financial’s Cardio Diagnostics CDIO Stock Holding History

HRT Financial’s Portfolio CDIO Stock Details CDIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-62,482
Closed -$121K – 4301
2026
Q1 		$121K Buy
+62,482
New +$163K ﹤0.01% 3313
2025
Q2 		– Sell
-1,488
Closed -$14K – 2707
2025
Q1 		$14K Sell
1,488
-3,692
-71% -$57.5K ﹤0.01% 2327
2024
Q4 		$142K Buy
5,180
+4,813
+1,311% +$66.7K ﹤0.01% 1999
2024
Q3 		$2K Buy
+367
New +$4.5K ﹤0.01% 2295
2023
Q4 		– Sell
-376
Closed -$3K – 2379
2023
Q3 		$3K Buy
+376
New +$9.04K ﹤0.01% 2216

Other funds holding CDIO

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

HRT Financial's CDIO Position: Q2 2026 in Review

HRT Financial sold out of Cardio Diagnostics (CDIO) in Q2 2026, closing a stake of 62,482 shares — an estimated $121K sold.

HRT Financial first reported a position in CDIO in Q3 2023 and held it in 5 quarters. The position peaked at $142K in Q4 2024. 17 funds tracked by Wall St. Rank hold CDIO as of Q2 2026.

  • HRT Financial reported no remaining Cardio Diagnostics position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 62,482 Cardio Diagnostics shares in Q2 2026, an estimated $121K.
  • HRT Financial first reported a position in Cardio Diagnostics in Q3 2023 and held it in 5 quarters.
  • HRT Financial's Cardio Diagnostics position peaked at $142K in Q4 2024.
  • 17 funds tracked by Wall St. Rank held Cardio Diagnostics as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.